NUR 555 Quiz 4 – 2026 Update Advanced Pathophysiology &
Pharmacologic Management Actual Exam 2026/2027 Complete
Exam-Style Questions with Detailed Rationales | 100% Verified |
Pass Guaranteed – A+ Graded
Core Concepts & Foundational Knowledge – Questions
Q1: In a patient with decompensated systolic heart failure, which neurohormonal
pathway is primarily responsible for the vicious cycle of vasoconstriction, sodium
retention, and ventricular remodeling over time?
A. Activation of the natriuretic peptide system leading to exaggerated diuresis and
hypovolemia
B. Upregulation of the parasympathetic nervous system causing bradycardia and
reduced cardiac output
C. Sustained activation of the renin-angiotensin-aldosterone system (RAAS) drives
pathologic vasoconstriction, volume overload, and adverse cardiac remodeling through
angiotensin II and aldosterone-mediated effects. [CORRECT]
D. Excessive nitric oxide release resulting in systemic hypotension and reflex tachycardia
Correct Answer: C
Rationale: The best answer is C. In systolic heart failure, the drop in cardiac output
triggers RAAS activation as a compensatory mechanism, but chronic stimulation by
angiotensin II and aldosterone actually worsens the condition by promoting
vasoconstriction, sodium and water retention, and fibrotic remodeling of the
myocardium. This is exactly why ACE inhibitors, ARBs, and MRAs are foundational
therapies—they interrupt this harmful cycle at its source.
,Q2: Which of the following pharmacokinetic changes is most consistently seen in older
adults (≥75 years) and significantly increases the risk of drug toxicity?
A. Increased hepatic blood flow leading to accelerated first-pass metabolism of oral
medications
B. Decreased glomerular filtration rate, reduced hepatic mass, and lower albumin levels
resulting in slower drug clearance and higher free drug concentrations [CORRECT]
C. Enhanced gastric acid secretion improving absorption of weakly acidic drugs
D. Increased total body water expanding the volume of distribution for lipophilic drugs
Correct Answer: B
Rationale: The best answer is B. As people age, renal function declines even with a
"normal" serum creatinine because muscle mass drops, hepatic enzyme activity and
blood flow decrease, and albumin levels fall—especially in frail or malnourished elders.
This means drugs cleared by the kidneys or metabolized by the liver hang around
longer, and more drug remains unbound and pharmacologically active, which is why
dosing adjustments and vigilant monitoring are non-negotiable in geriatric
pharmacotherapy.
Q3: A patient with type 2 diabetes and established atherosclerotic cardiovascular
disease is started on a medication from the SGLT2 inhibitor class. What is the primary
cardioprotective mechanism thought to underlie the reduced hospitalization for heart
failure seen in this population?
A. Direct stimulation of pancreatic beta cells to enhance endogenous insulin secretion
B. Increased urinary glucose excretion leading to osmotic diuresis, reduced plasma
volume, and improved cardiac preload along with favorable shifts in cardiac metabolism
[CORRECT]
C. Competitive antagonism of aldosterone receptors in the distal renal tubule
, D. Inhibition of the sodium-glucose cotransporter in the proximal tubule causing severe
hypoglycemia and reduced myocardial workload
Correct Answer: B
Rationale: The best answer is B. SGLT2 inhibitors like empagliflozin and dapagliflozin
lower blood glucose by dumping it in the urine, but the heart benefits go well beyond
glycemic control—they produce a modest osmotic diuresis that eases preload, improve
ventricular loading conditions, and shift cardiac metabolism toward more efficient
ketone and fatty acid utilization, all of which contribute to the robust reduction in heart
failure hospitalizations seen in outcome trials.
Q4: Which laboratory finding best distinguishes acute kidney injury (AKI) from chronic
kidney disease (CKD) in a patient presenting with elevated serum creatinine?
A. A urine sodium level >40 mEq/L indicating tubular dysfunction
B. The presence of normocytic anemia with a hemoglobin of 9.2 g/dL
C. Normal or enlarged kidney size on ultrasound with absent cortical thinning,
suggesting a recent rather than long-standing process [CORRECT]
D. A blood urea nitrogen-to-creatinine ratio >20:1 consistent with prerenal azotemia
Correct Answer: C
Rationale: The best answer is C. In chronic kidney disease, the kidneys typically shrink
and develop echogenic, thinned cortices over months to years due to progressive
fibrosis and nephron loss, whereas in acute kidney injury the kidneys usually maintain
normal size and architecture because the damage is recent and potentially reversible.
While the other options can appear in either condition depending on the cause, renal
ultrasound findings provide the clearest structural distinction between acute and chronic
processes.
Pharmacologic Management Actual Exam 2026/2027 Complete
Exam-Style Questions with Detailed Rationales | 100% Verified |
Pass Guaranteed – A+ Graded
Core Concepts & Foundational Knowledge – Questions
Q1: In a patient with decompensated systolic heart failure, which neurohormonal
pathway is primarily responsible for the vicious cycle of vasoconstriction, sodium
retention, and ventricular remodeling over time?
A. Activation of the natriuretic peptide system leading to exaggerated diuresis and
hypovolemia
B. Upregulation of the parasympathetic nervous system causing bradycardia and
reduced cardiac output
C. Sustained activation of the renin-angiotensin-aldosterone system (RAAS) drives
pathologic vasoconstriction, volume overload, and adverse cardiac remodeling through
angiotensin II and aldosterone-mediated effects. [CORRECT]
D. Excessive nitric oxide release resulting in systemic hypotension and reflex tachycardia
Correct Answer: C
Rationale: The best answer is C. In systolic heart failure, the drop in cardiac output
triggers RAAS activation as a compensatory mechanism, but chronic stimulation by
angiotensin II and aldosterone actually worsens the condition by promoting
vasoconstriction, sodium and water retention, and fibrotic remodeling of the
myocardium. This is exactly why ACE inhibitors, ARBs, and MRAs are foundational
therapies—they interrupt this harmful cycle at its source.
,Q2: Which of the following pharmacokinetic changes is most consistently seen in older
adults (≥75 years) and significantly increases the risk of drug toxicity?
A. Increased hepatic blood flow leading to accelerated first-pass metabolism of oral
medications
B. Decreased glomerular filtration rate, reduced hepatic mass, and lower albumin levels
resulting in slower drug clearance and higher free drug concentrations [CORRECT]
C. Enhanced gastric acid secretion improving absorption of weakly acidic drugs
D. Increased total body water expanding the volume of distribution for lipophilic drugs
Correct Answer: B
Rationale: The best answer is B. As people age, renal function declines even with a
"normal" serum creatinine because muscle mass drops, hepatic enzyme activity and
blood flow decrease, and albumin levels fall—especially in frail or malnourished elders.
This means drugs cleared by the kidneys or metabolized by the liver hang around
longer, and more drug remains unbound and pharmacologically active, which is why
dosing adjustments and vigilant monitoring are non-negotiable in geriatric
pharmacotherapy.
Q3: A patient with type 2 diabetes and established atherosclerotic cardiovascular
disease is started on a medication from the SGLT2 inhibitor class. What is the primary
cardioprotective mechanism thought to underlie the reduced hospitalization for heart
failure seen in this population?
A. Direct stimulation of pancreatic beta cells to enhance endogenous insulin secretion
B. Increased urinary glucose excretion leading to osmotic diuresis, reduced plasma
volume, and improved cardiac preload along with favorable shifts in cardiac metabolism
[CORRECT]
C. Competitive antagonism of aldosterone receptors in the distal renal tubule
, D. Inhibition of the sodium-glucose cotransporter in the proximal tubule causing severe
hypoglycemia and reduced myocardial workload
Correct Answer: B
Rationale: The best answer is B. SGLT2 inhibitors like empagliflozin and dapagliflozin
lower blood glucose by dumping it in the urine, but the heart benefits go well beyond
glycemic control—they produce a modest osmotic diuresis that eases preload, improve
ventricular loading conditions, and shift cardiac metabolism toward more efficient
ketone and fatty acid utilization, all of which contribute to the robust reduction in heart
failure hospitalizations seen in outcome trials.
Q4: Which laboratory finding best distinguishes acute kidney injury (AKI) from chronic
kidney disease (CKD) in a patient presenting with elevated serum creatinine?
A. A urine sodium level >40 mEq/L indicating tubular dysfunction
B. The presence of normocytic anemia with a hemoglobin of 9.2 g/dL
C. Normal or enlarged kidney size on ultrasound with absent cortical thinning,
suggesting a recent rather than long-standing process [CORRECT]
D. A blood urea nitrogen-to-creatinine ratio >20:1 consistent with prerenal azotemia
Correct Answer: C
Rationale: The best answer is C. In chronic kidney disease, the kidneys typically shrink
and develop echogenic, thinned cortices over months to years due to progressive
fibrosis and nephron loss, whereas in acute kidney injury the kidneys usually maintain
normal size and architecture because the damage is recent and potentially reversible.
While the other options can appear in either condition depending on the cause, renal
ultrasound findings provide the clearest structural distinction between acute and chronic
processes.
